Luis Rosas-Vidal is a Psychiatry physician affiliated with Northwestern University. OpenAlex indexes 15 publications with 540 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
676 N Saint Clair St Ste 1100
Chicago, IL 606112954
Telephone
312-695-5060Provider last certified this registry record 14 Nov 2022.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
92.5%SSRI26.9%Trazodone Hcl28%Sertraline Hcl26%Paroxetine Hcl13%Escitalopram Oxalate12%Fluoxetine Hcl12%Fluvoxamine Maleate10%Part D<11 patientsAtypical Antipsychotic23.4%Quetiapine Fumarate40%Olanzapine18%Risperidone18%Clozapine13%Aripiprazole11%Part D<11 patients+ 10 more classes in this area
Cardiovascular
3.8%Beta blocker2.1%Propranolol Hcl100%Part D<11 patientsalpha-Adrenergic Blocker1.8%Prazosin Hcl100%Part D<11 patientsMetabolism & gastrointestinal
3.7%Biguanide (metformin)3.7%Metformin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2024 per NIH RePORTER. The latest:
- Opioid-BNST interactions in the regulation of trauma-induced anxiety states
Northwestern University at Chicago
FY2024$181,915K08MH126166 - Opioid-BNST interactions in the regulation of trauma-induced anxiety states
Northwestern University at Chicago
FY2023$181,915K08MH126166 - Opioid-BNST interactions in the regulation of trauma-induced anxiety states
Northwestern University at Chicago
FY2022$144,630K08MH126166
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prefrontal correlates of fear generalization during endocannabinoid depletion
Journal of Clinical Investigation
2025 - PREFRONTAL CORRELATES OF FEAR GENERALIZATION DURING ENDOCANNABINOID DEPLETION
bioRxiv (Cold Spring Harbor Laboratory)
2024 - PHARMACOLOGICAL DIACYLGLYCEROL LIPASE INHIBITION IMPAIRS CONTEXTUAL FEAR EXTINCTION IN MICE
IBRO Neuroscience Reports
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”